Ibrahim Nassour, MD, MSCS
Assistant Professor
Department:
MD-SURGERY-SURGONC-PBS
Business Phone:
(352) 594-5132
Business Email:
ibrahimnassour@ufl.edu
About Ibrahim Nassour
Ibrahim Nassour, MD, MSCS is an assistant professor, with the Division of Surgical Oncology at the University of Florida College of Medicine. At UF Health, Dr. Nassour specializes in surgeries for cancers of the gastrointestinal tract, pancreas, liver and bile duct. He has special interest in robotic pancreato-biliary surgery including robotic pancreaticoduodenectomy (Whipple procedure) and in regional therapies for metastatic disease.
Dr. Nassour earned his medical degree from the American University of Beirut where he was inducted into the Alpha Omega Alpha Honor Medical Society. He completed his general surgery residency at the Johns Hopkins University School of Medicine and the University of Texas Southwestern Medical Center. During his training, he pursued a postdoctoral research fellowship and received a master’s degree in clinical and translational science. Most recently Dr. Nassour received advanced training in complex general surgical oncology at the University of Pittsburgh Medical Center.
Dr. Nassour’s research focuses on comparative effectiveness studies that evaluate the role of minimally invasive and robotic surgery as well as the role of neoadjuvant therapy in the management of pancreato-biliary cancers. In addition, he is interested in designing clinical trials that incorporate liquid biopsies and adaptive neoadjuvant therapies in the management of pancreato-biliary malignancies with the goal to improve and optimize the care of cancer patients. His research has been published in multiple peer-reviewed journals and books.
Dr. Nassour is board certified surgeon by the American Board of Surgery. He is a member of the Association for Academic Surgery, the Society of Surgical Oncology, the Americas Hepato-Pancreato-Biliary Association and the American College of Surgeons.
Accomplishments
Finalist for the clinical poster award
2018
·
Society of Surgical Oncology
Winner of the ACS surgical skill competition
2018
·
American College of Surgeons
Award for best basic/translational research poster
2017
·
Society of Surgical Oncology
Award for best oncology paper
2017
·
North and south chapters of the American College of Surgeons
Award for best oral presentation: runner-up
2017
·
36th annual Parkland surgical society meeting
Alpha Omega Alpha postgraduate award
2016
·
Alpha Omega Alpha
Award for best oral presentation
2016
·
Surgery Research Day, UT Southwestern
Award for best oral presentation: runner-up
2012
·
o Tenth Annual Richard L. Simmons Lecture and Department of Surgery Research Day, University of Pittsburgh
Naji Sahyoun Memorial Award
2011
·
American University of Beirut
Alpha Omega Alpha Society
2010
·
American University of Beirut
Board Certifications
-
SurgeryAmerican Board of Surgery
Clinical Profile
Specialties
- Cancer
- Surgical Oncology
Areas of Interest
- Cancer treatment information
- Cholangiocarcinoma
- Gastrointestinal Oncology Surgery
- Gastrointestinal cancer
- Inflammatory bowel disease
- Liver metastases
- Pancreatic cancer
- Pancreatitis
- Robotic surgery
Research Profile
Open Researcher and Contributor ID (ORCID)
0000-0002-9845-1074
Areas of Interest
- Adrenal tumors
- Extrahepatic cholangiocarcinoma
- GIST
- Gastric cancer
- Laparoscopic surgery
- Liquid biopsies
- Liver metastasis- colorectal, neuroendocrine and other non-colorectal non-neuroendocrine metastasis
- Neoadjuvant therapy in the management of pancreato-biliary cancers
- Pancreatic cyst (Cystadenoma, Mucinous Cystic Neoplasm, Intraductal Papillary Mucinous Neoplasm)
- Pancreatic neuroendocrine
- Peritoneal surface malignancies
- Small bowel cancer
Publications
2024
Analysis of pancreatic cancer treatment and survival disparities in Florida throughout the Covid-19 pandemic.
Journal of the National Medical Association.
116(4):328-337
[DOI] 10.1016/j.jnma.2024.07.004.
[PMID] 39107147.
2024
Postoperative infectious complications worsen oncologic outcomes following pancreaticoduodenectomy for pancreatic ductal adenocarcinoma.
Journal of surgical oncology.
129(6):1097-1105
[DOI] 10.1002/jso.27595.
[PMID] 38316936.
2023
A phase II study of neoadjuvant liposomal irinotecan with 5-FU and oxaliplatin (NALIRIFOX) in pancreatic adenocarcinoma.
Future oncology (London, England).
19(27):1841-1851
[DOI] 10.2217/fon-2023-0256.
[PMID] 37753702.
2023
A protein-based machine learning approach to the identification of inflammatory subtypes in pancreatic ductal adenocarcinoma
Pancreatology.
23(6):615-621
[DOI] 10.1016/j.pan.2023.06.007.
[PMID] 37391359.
2023
Addendum: Importance of carbohydrate antigen (CA 19-9) and carcinoembrionic antigen (CEA) in the prognosis of patients with duodenal adenocarcinoma: a retrospective single-institution cohort study.
Oncotarget.
14
[DOI] 10.18632/oncotarget.28491.
[PMID] 38085073.
2023
Appendectomy Is Oncologically Equivalent to Right Hemicolectomy for Well-Differentiated T1 Appendiceal Adenocarcinoma.
Diseases of the colon and rectum.
66(1):67-74
[DOI] 10.1097/DCR.0000000000002089.
[PMID] 34508015.
2023
Changing Practice Patterns and Improving Survival for Patients with Pancreatic Ductal Adenocarcinoma
Cancers.
15(18)
[DOI] 10.3390/cancers15184464.
[PMID] 37760433.
2023
Impact of Biopsy Attempts, Race, and Access on Time to Initiation of Treatment for Pancreatic Cancer.
Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract.
27(11):2474-2483
[DOI] 10.1007/s11605-022-05531-6.
[PMID] 37740146.
2023
Impact of Extended Antibiotic Use After Pancreaticoduodenectomy for Patients with Preoperative Metallic Biliary Stenting Treated with Neoadjuvant Chemotherapy.
Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract.
27(4):716-723
[DOI] 10.1007/s11605-023-05581-4.
[PMID] 36650416.
2023
Importance of carbohydrate antigen (CA 19-9) and carcinoembrionic antigen (CEA) in the prognosis of patients with duodenal adenocarcinoma: a retrospective single-institution cohort study.
Oncotarget.
14:351-357
[DOI] 10.18632/oncotarget.28406.
[PMID] 37068159.
2023
Low vs Standard-Dose Indocyanine Green in the Identification of Biliary Anatomy Using Near-Infrared Fluorescence Imaging: A Multicenter Randomized Controlled Trial.
Journal of the American College of Surgeons.
236(4):711-717
[DOI] 10.1097/XCS.0000000000000553.
[PMID] 36728303.
2023
National adoption of neoadjuvant chemotherapy: paradigm shift in the treatment of pancreatic cancer
HPB.
25(11):1323-1328
[DOI] 10.1016/j.hpb.2023.06.018.
2023
Pancreaticoduodenectomy for benign and premalignant pancreatic and ampullary disease: is robotic surgery the better approach?
Surgical endoscopy.
37(2):1157-1165
[DOI] 10.1007/s00464-022-09632-w.
[PMID] 36138252.
2023
Prognosis and Treatment Outcomes of Bone Metastasis in Gallbladder Adenocarcinoma: A SEER-Based Study
Cancers.
15(20)
[DOI] 10.3390/cancers15205055.
[PMID] 37894422.
2023
Robotic Pancreaticoduodenectomy: Increased Adoption and Improved Outcomes: Is Laparoscopy Still Justified?
Annals of surgery.
278(3):e563-e569
[DOI] 10.1097/SLA.0000000000005687.
[PMID] 36000753.
2023
The risk of clinically-relevant pancreatic fistula after pancreaticoduodenectomy is better predicted by a postoperative trend in drain fluid amylase compared to day 1 values in isolation.
Surgery.
[DOI] 10.1016/j.surg.2023.06.009.
[PMID] 37468367.
2023
The use of angiotensin system inhibitors correlates with longer survival in resected pancreatic adenocarcinoma patients.
HPB : the official journal of the International Hepato Pancreato Biliary Association.
25(3):320-329
[DOI] 10.1016/j.hpb.2022.12.002.
[PMID] 36610939.
2022
Adaptive Dynamic Therapy and Survivorship for Operable Pancreatic Cancer.
JAMA network open.
5(6)
[DOI] 10.1001/jamanetworkopen.2022.18355.
[PMID] 35737385.
2022
Arid1a loss potentiates pancreatic β-cell regeneration through activation of EGF signaling.
Cell reports.
41(5)
[DOI] 10.1016/j.celrep.2022.111581.
[PMID] 36323264.
2022
Chemotherapy is associated with improved survival in a national cohort of stage IV pancreatic adenosquamous carcinoma.
Journal of gastrointestinal oncology.
13(6):3207-3215
[DOI] 10.21037/jgo-22-434.
[PMID] 36636088.
2022
Clinical Trials in Hepatopancreatobiliary Surgery: Assessing Trial Characteristics, Early Discontinuation, Result Reporting, and Publication.
Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract.
26(8):1628-1636
[DOI] 10.1007/s11605-022-05387-w.
[PMID] 35713764.
2022
From bench to bedside: Pursuing equity in precision medicine approaches to pancreatic cancer care.
Frontiers in oncology.
12
[DOI] 10.3389/fonc.2022.1086779.
[PMID] 36568255.
2022
Lenvatinib inhibits the growth of gastric cancer patient-derived xenografts generated from a heterogeneous population.
Journal of translational medicine.
20(1)
[DOI] 10.1186/s12967-022-03317-7.
[PMID] 35255940.
2022
Novel Calculator to Estimate the Risk of Clinically Relevant Postoperative Pancreatic Fistula Following Distal Pancreatectomy.
Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract.
26(7):1436-1444
[DOI] 10.1007/s11605-022-05275-3.
[PMID] 35352209.
2022
The Role of Adjuvant Chemotherapy Following Right Hemicolectomy for Non-metastatic Mucinous and Nonmucinous Appendiceal Adenocarcinoma
Journal of Gastrointestinal Surgery.
26(1):171-180
[DOI] 10.1007/s11605-021-05076-0.
2022
Transanal excision with adjuvant therapy for pT1N0 rectal tumors with high-risk features offers equivalent survival to radical resection: A National Cancer Database analysis.
Journal of surgical oncology.
125(3):475-483
[DOI] 10.1002/jso.26734.
[PMID] 34705273.
2021
A National Assessment of Optimal Oncologic Surgery for Distal Pancreatic Adenocarcinomas.
Pancreas.
50(3):386-392
[DOI] 10.1097/MPA.0000000000001786.
[PMID] 33835970.
2021
ASO Author Reflections: Use of a National Database to Determine the Optimal Surgical Intervention for a Rare Appendiceal Cancer.
Annals of surgical oncology.
28(13):8926-8927
[DOI] 10.1245/s10434-021-10310-9.
[PMID] 34159475.
2021
Association Between Medicaid Expansion and Diagnosis and Management of Colon Cancer.
Journal of the American College of Surgeons.
232(2):146-156.e1
[DOI] 10.1016/j.jamcollsurg.2020.10.021.
[PMID] 33242599.
2021
Borderline Resectable and Locally Advanced Pancreatic Cancers: A Review of Definitions, Diagnostics, Strategies for Treatment, and Future Directions.
Pancreas.
50(9):1243-1249
[DOI] 10.1097/MPA.0000000000001924.
[PMID] 34860806.
2021
Encouraging long-term survival following autophagy inhibition using neoadjuvant hydroxychloroquine and gemcitabine for high-risk patients with resectable pancreatic carcinoma.
Cancer medicine.
10(20):7233-7241
[DOI] 10.1002/cam4.4211.
[PMID] 34559451.
2021
Impact of Resection Margin Status in Patients with Pancreatic Cancer: a National Cohort Study.
Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract.
25(9):2307-2316
[DOI] 10.1007/s11605-020-04870-6.
[PMID] 33269460.
2021
Medicaid expansion and the management of pancreatic cancer
Journal of Surgical Oncology.
124(3):324-333
[DOI] 10.1002/jso.26515.
[PMID] 33939838.
2021
Minimally Invasive Techniques for Pancreatic Resection.
Surgical oncology clinics of North America.
30(4):747-758
[DOI] 10.1016/j.soc.2021.06.007.
[PMID] 34511194.
2021
National Trends in Robotic Pancreas Surgery.
Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract.
25(4):983-990
[DOI] 10.1007/s11605-020-04591-w.
[PMID] 32314230.
2021
Neoadjuvant Chemotherapy for Pancreatic Adenocarcinoma Lessens the Deleterious Effect of Omission of Adjuvant Chemotherapy.
Annals of surgical oncology.
28(7):3800-3807
[DOI] 10.1245/s10434-020-09446-x.
[PMID] 33386547.
2021
Neoadjuvant therapy versus upfront surgery for early‐stage left‐sided pancreatic adenocarcinoma: A propensity‐matched analysis from a national cohort of distal pancreatectomies
Journal of Surgical Oncology.
123(1):245-251
[DOI] 10.1002/jso.26267.
2021
Omission of Right Hemicolectomy May be Safe for Some Appendiceal Goblet Cell Adenocarcinomas: A Survival Analysis of the National Cancer Database.
Annals of surgical oncology.
28(13):8916-8925
[DOI] 10.1245/s10434-021-10191-y.
[PMID] 34409541.
2021
Pathologic Complete Response Following Neoadjuvant Therapy for Gastric Adenocarcinoma: A National Cancer Database Analysis on Incidence, Predictors, and Outcomes.
The American surgeon.
87(7):1145-1154
[DOI] 10.1177/0003134820972083.
[PMID] 33342268.
2021
Patient Factors Limit Colon Cancer Survival at Safety-Net Hospitals: A National Analysis.
The Journal of surgical research.
264:279-286
[DOI] 10.1016/j.jss.2021.03.012.
[PMID] 33839343.
2021
Perioperative and oncologic outcomes of open, laparoscopic, and robotic distal pancreatectomy for pancreatic adenocarcinoma.
Updates in surgery.
73(3):947-953
[DOI] 10.1007/s13304-020-00927-y.
[PMID] 33394353.
2021
Predictors of early recurrence following neoadjuvant chemotherapy and surgical resection for localized pancreatic adenocarcinoma
Journal of Surgical Oncology.
124(3):308-316
[DOI] 10.1002/jso.26510.
[PMID] 33893740.
2021
Safety and oncologic efficacy of robotic compared to open pancreaticoduodenectomy after neoadjuvant chemotherapy for pancreatic cancer
Surgical Endoscopy.
35(5):2248-2254
[DOI] 10.1007/s00464-020-07638-w.
2021
The Role of Adjuvant Chemotherapy in Non-Metastatic Goblet Cell Carcinoid of the Appendix: An 11-Year Experience from the National Cancer Database.
Annals of surgical oncology.
28(7):3873-3881
[DOI] 10.1245/s10434-020-09389-3.
[PMID] 33231767.
2020
Hispanic/Latino Patients with Gastric Adenocarcinoma Have Distinct Molecular Profiles Including a High Rate of GermlineCDH1Variants
Cancer Research.
80(11):2114-2124
[DOI] 10.1158/0008-5472.can-19-2918.
2020
Long‐term oncologic outcomes of robotic and open pancreatectomy in a national cohort of pancreatic adenocarcinoma
Journal of Surgical Oncology.
122(2):234-242
[DOI] 10.1002/jso.25958.
2020
Long‐term survival following minimally invasive extended cholecystectomy for gallbladder cancer: A 7‐year experience from the National Cancer Database
Journal of Surgical Oncology.
122(4):707-715
[DOI] 10.1002/jso.26062.
2020
Predictors and outcomes of converted minimally invasive pancreaticoduodenectomy: a propensity score matched analysis.
Surgical endoscopy.
34(2):544-550
[DOI] 10.1007/s00464-019-06792-0.
[PMID] 31016458.
2020
Successful Mentor-Mentee Relationship.
The Journal of surgical research.
247:332-334
[DOI] 10.1016/j.jss.2019.09.066.
[PMID] 31733816.
2019
Laparoscopic Cholecystectomy is Safe Both Day and Night.
The Journal of surgical research.
233:163-166
[DOI] 10.1016/j.jss.2018.07.071.
[PMID] 30502243.
2019
Mitotic regulators and the SHP2-MAPK pathway promote IR endocytosis and feedback regulation of insulin signaling.
Nature communications.
10(1)
[DOI] 10.1038/s41467-019-09318-3.
[PMID] 30931927.
2019
SWI/SNF component ARID1A restrains pancreatic neoplasia formation.
Gut.
68(7):1259-1270
[DOI] 10.1136/gutjnl-2017-315490.
[PMID] 30315093.
2018
Adjuvant Therapy Is Associated With Improved Survival in Resected Perihilar Cholangiocarcinoma: A Propensity Matched Study.
Annals of surgical oncology.
25(5):1193-1201
[DOI] 10.1245/s10434-018-6388-7.
[PMID] 29488187.
2018
Adoption of evidence‐based novel therapies in the treatment of gastric cancer: A national observational study
Cancer.
124(6):1122-1131
[DOI] 10.1002/cncr.31179.
2018
Arid1a Has Context-Dependent Oncogenic and Tumor Suppressor Functions in Liver Cancer.
Cancer cell.
33(1):151-152
[DOI] 10.1016/j.ccell.2017.12.011.
[PMID] 29316428.
2018
ASO Author Reflections: Use of Retrospective Administrative Datasets in Rare Cancer Subtypes to Determine the Efficacy of Adjuvant Therapy.
Annals of surgical oncology.
25(Suppl 3):798-799
[DOI] 10.1245/s10434-018-7031-3.
[PMID] 30421055.
2018
Association of Adjuvant Therapy with Improved Survival in Ampullary Cancer: A National Cohort Study.
Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract.
22(4):695-702
[DOI] 10.1007/s11605-017-3624-6.
[PMID] 29127604.
2018
Determining the Adequate Examined Lymph Node Count in Resected Ampullary Adenocarcinoma—A National Cohort Study
Journal of Gastrointestinal Surgery.
22(5):792-801
[DOI] 10.1007/s11605-018-3737-6.
2018
Improved Survival in Surgically Resected Distal Cholangiocarcinoma Treated with Adjuvant Therapy: a Propensity Score Matched Analysis.
Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract.
22(12):2080-2087
[DOI] 10.1007/s11605-018-3875-x.
[PMID] 30030718.
2018
Knockdown of Anillin Actin Binding Protein Blocks Cytokinesis in Hepatocytes and Reduces Liver Tumor Development in Mice Without Affecting Regeneration.
Gastroenterology.
154(5):1421-1434
[DOI] 10.1053/j.gastro.2017.12.013.
[PMID] 29274368.
2018
Minimally Invasive Versus Open Pancreaticoduodenectomy: A Propensity-matched Study From a National Cohort of Patients.
Annals of surgery.
268(1):151-157
[DOI] 10.1097/SLA.0000000000002259.
[PMID] 28486387.
2018
Racial and ethnic disparities in a national cohort of ampullary cancer patients
Journal of Surgical Oncology.
117(2):220-227
[DOI] 10.1002/jso.24835.
[PMID] 28968918.
2018
Reply to Grant, William: Obesity and vitamin D status may help explain the racial and ethnic disparities in ampullary cancer survival rates
Journal of Surgical Oncology.
117(6):1343-1343
[DOI] 10.1002/jso.24952.
2018
Robotic-assisted versus laparoscopic pancreaticoduodenectomy: oncological outcomes
Surgical Endoscopy.
32(6):2907-2913
[DOI] 10.1007/s00464-017-6002-2.
2017
Arid1a Has Context-Dependent Oncogenic and Tumor Suppressor Functions in Liver Cancer.
Cancer cell.
32(5):574-589.e6
[DOI] 10.1016/j.ccell.2017.10.007.
[PMID] 29136504.
2017
Arid1b haploinsufficient mice reveal neuropsychiatric phenotypes and reversible causes of growth impairment.
eLife.
6
[DOI] 10.7554/eLife.25730.
[PMID] 28695822.
2017
Conversion of Minimally Invasive Distal Pancreatectomy: Predictors and Outcomes.
Annals of surgical oncology.
24(12):3725-3731
[DOI] 10.1245/s10434-017-6062-5.
[PMID] 28849407.
2017
Current Management of Peritoneal Carcinomatosis From Colorectal Cancer: The Role of Cytoreductive Surgery and Hyperthermic Peritoneal Chemoperfusion.
Current colorectal cancer reports.
13(2):144-153
[PMID] 28890671.
2017
Metabolic syndrome remission after Roux-en-Y gastric bypass or sleeve gastrectomy.
Diabetes, metabolic syndrome and obesity : targets and therapy.
10:393-402
[DOI] 10.2147/DMSO.S142731.
[PMID] 29033596.
2017
Nomogram to predict non-home discharge following pancreaticoduodenectomy in a national cohort of patients.
HPB : the official journal of the International Hepato Pancreato Biliary Association.
19(12):1037-1045
[DOI] 10.1016/j.hpb.2017.07.011.
[PMID] 28867297.
2017
Robotic Versus Laparoscopic Pancreaticoduodenectomy: a NSQIP Analysis.
Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract.
21(11):1784-1792
[DOI] 10.1007/s11605-017-3543-6.
[PMID] 28819886.
2017
The surgeon-performed ultrasound: a curriculum to improve residents’ basic ultrasound knowledge
Journal of Surgical Research.
213:51-59
[DOI] 10.1016/j.jss.2017.02.031.
[PMID] 28601332.
2017
The Yield of Staging Laparoscopy in Gastric Cancer is Affected by Racial and Ethnic Differences in Disease Presentation.
Annals of surgical oncology.
24(7):1787-1794
[DOI] 10.1245/s10434-017-5805-7.
[PMID] 28194592.
2016
Diagnosis and Treatment of Pancreatic Cystic Neoplasms.
JAMA.
316(12)
[DOI] 10.1001/jama.2016.9130.
[PMID] 27673319.
2016
Minimally Invasive Liver Surgery for Hepatic Colorectal Metastases.
Current colorectal cancer reports.
12(2):103-112
[PMID] 27570500.
2016
Pancreatic Operations.
JAMA.
316(18)
[DOI] 10.1001/jama.2016.11165.
[PMID] 27825010.
2016
Robotic cystogastrostomy and debridement of walled-off pancreatic necrosis.
Journal of robotic surgery.
10(3):279-82
[DOI] 10.1007/s11701-016-0581-0.
[PMID] 27039191.
2016
Suppression of the SWI/SNF Component Arid1a Promotes Mammalian Regeneration.
Cell stem cell.
18(4):456-66
[DOI] 10.1016/j.stem.2016.03.001.
[PMID] 27044474.
2016
Types of Pancreatic Cysts.
JAMA.
316(11)
[DOI] 10.1001/jama.2016.9035.
[PMID] 27654619.
2015
Carbon monoxide protects against hemorrhagic shock and resuscitation-induced microcirculatory injury and tissue injury.
Shock (Augusta, Ga.).
43(2):166-71
[DOI] 10.1097/SHK.0000000000000264.
[PMID] 25243427.
2015
Gastrointestinal perforation.
JAMA surgery.
150(2):177-8
[DOI] 10.1001/jamasurg.2014.358.
[PMID] 25549241.
2015
Inhaled Carbon Monoxide Protects against the Development of Shock and Mitochondrial Injury following Hemorrhage and Resuscitation.
PloS one.
10(9)
[DOI] 10.1371/journal.pone.0135032.
[PMID] 26366865.
2014
Polymicrobial sepsis is associated with decreased hepatic oxidative phosphorylation and an altered metabolic profile.
The Journal of surgical research.
186(1):297-303
[DOI] 10.1016/j.jss.2013.08.007.
[PMID] 24054495.
2012
Novel management strategies in the treatment of severe Clostridium difficile infection.
Advances in surgery.
46:111-35
[PMID] 22873036.
2012
Prognostic significance of gelsolin and MMP12 in Langerhans cell histiocytosis.
The Korean journal of hematology.
47(4):267-72
[DOI] 10.5045/kjh.2012.47.4.267.
[PMID] 23320005.
Grants
Dec 2020
ACTIVE
Optimal Perioperative Therapy For Incidental Gallbladder Cancer (OPT-IN): A Randomized Phase II/III Trial
Role: Principal Investigator
Funding: NRG ONCOLOGY FOU
via NATL INST OF HLTH NCI
Jul 2020
ACTIVE
Phase III Trial of Perioperative Versus Adjuvant Chemotherapy for Resectable Pancreatic Cancer
Role: Principal Investigator
Funding: NRG ONCOLOGY FOU
via NATL INST OF HLTH NCI
Education
Fellowship in Complex General Surgical Oncology
2019-2021
·
University of Pittsburgh Medical Center
Master of Science in Clinical and Translational Science
2015-2017
·
University of Texas Southwestern
Residency in General Surgery
2014-2019
·
University of Texas Southwestern Medical Center
Residency in General Surgery
2012-2014
·
Johns Hopkins Hospital
Research fellowship
2011-2012
·
University of Pittsburgh Medical Center
Medical Degree
2007-2011
·
American University of Beirut
Contact Details
Phones:
- Business:
- (352) 594-5132
Emails:
- Business:
- ibrahimnassour@ufl.edu
Administrative Spec II:
Addresses: